Active filters
Displaying 1-50 of 462 results
Regulatory policies of the Food and Drug Administration. Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, second session, June 9, 1970.
Book/text
Washington, U. S. Govt. Print. Off. [1971]
1971
1 item
Call number | JLE 74-3126 (HSSL) |
Item location | Offsite |
Recall procedures of the Food and Drug Administration. Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. March 29, 1971.
Book/text
Washington, U. S. Govt. Print. Off., 1971.
1971
1 item
Call number | JLE 76-734 |
Item location | Offsite |
The mirage of safety : food additives and Federal policy / by Beatrice Trum Hunter.
Book/text
New York : Scribner, c1975.
1975
1 item
Call number | JSD 76-254 |
Item location | Offsite |
Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, second session, [-Ninety-fourth Congress, first session.]
Book/text
Washington : U. S. Govt. Print. Off., 1974-76
1974
2 items
Call number | JLL 76-387 |
Item location | Offsite |
Call number | JLL 76-387 |
Item location | Offsite |
Regulation of new drug R. & D. by the Food and Drug Administration, 1974 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session ... September 25 and 27, 1974.
Book/text
Washington : U. S. Govt. Print. Off., 1974.
1974
1 item
Call number | JLE 76-2403 |
Item location | Offsite |
Preclinical and clinical testing by the pharmaceutical industry, 1975- : joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session-[second] session ....
Book/text
Washington : U.S. Govt. Print. Off., 1975-
1975
4 items
Call number | JLL 77-375 |
Item location | Offsite |
Call number | JLL 77-375 |
Item location | Offsite |
Call number | JLL 77-375 |
Item location | Offsite |
The therapeutic nightmare; a report on the roles of the United States Food and Drug Administration, the American Medical Association, pharmaceutical manufacturers, and others in connection with the irrational and massive use of prescription drugs that may be worthless, injurious, or even lethal.
Book/text
Boston, Houghton Mifflin, 1965.
1965
1 item
Call number | D-16 5573 |
Item location | Schwarzman Building - Main Reading Room 315 |
Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Drug safety : most drugs withdrawn in recent years had greater health risks for women / United States General Accounting Office.
Web resource
Washington, D.C. : The Office, [2001]
2001
1 resource
Available online
Document requests : response time to congressional committees could be improved : report to the Commissioner, Food and Drug Administration, Department of Health and Human Services / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor], [1987]
1987
0 resources
Freedom of information : FDA's program and regulations need improvement : report to the Chairman, Subcommittee on Government Information, Justice, and Agriculture, Committee on Government Operations, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor], [1991]
1991
1 resource
Available online
Medical technology : implementing the Good Manufacturing Practices Regulation : statement of Eleanor Chelimsky, Assistant Comptroller General, Program Evaluation and Methodology Division, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office.
Microform
[Washington, D.C.] : The Office ; [Gaithersburg, MD] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
FDA regulations : sustained management attention needed to improve timely issuance : statement of Mark V. Nadel, Associate Director, National and Public Health Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office.
Microform
[Washington, D.C.] : The Office ; [Gaithersburg, MD] (P.O. Box 6015, Gaithersburg 20844-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Over the counter drugs : gaps and potential vulnerabilities in the regulatory system : statement of Kwai-Cheung Chan, Director of Program Evaluation in Physical Systems Areas, Program Evaluation and Methodology Division, before the Subcommittee on Regulation, Business Opportunities and Energy, Committee on Small Business, House of Representatives / United States General Accounting Office.
Microform
[Washington, D.C.] : The Office ; [Gaithersburg, MD] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Food tampering : FDA's actions on Chilean fruit based on sound evidence : report to the ranking minority member, Committee on Foreign Relations, U.S. Senate / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1990]
1990
0 resources
Recombinant bovine growth hormone : FDA approval should be withheld until the mastitis issue is resolved : report to congressional requesters / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Women's health : FDA needs to ensure more study of gender differences in prescription drug testing : report to congressional requesters / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Medical technology : for some cardiac pacemaker leads, the public health risks are still high : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Hollow government : the Food and Drug Administration : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, July 25, 1991.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993.
1993
1 resource
Available online
Hospital sterilants : insufficient FDA regulation may pose a public health risk : report to the Ranking Minority Member, Committee on Government Operations, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1993]
1993
1 resource
Available online
FDA's FOIA fees / United States General Accounting Office, General Government Division.
Microform
Washington, D.C. : The Office ; [Gaithersburg, Md.] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1993]
1993
1 resource
Available online
Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994.
1994
1 resource
Available online
FDA's inspection of imported dairy products / United States General Accounting Office, Resources, Community, and Economic Development Division.
Microform
Washington, D.C. : The Office ; [Gaithersburg, Md.] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1992]
1992
1 resource
Available online
Food safety and quality : innovative strategies may be needed to regulate new food technologies : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1993]
1993
0 resources
FDA safety devices / United States General Accounting Office, Human Resources Division.
Microform
Washington, D.C. : The Office ; [Gaithersburg, Md.] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1994]
1994
0 resources
FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1994]
1994
0 resources
A consumer's perspective on medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, March 30, 1995.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.
1995
1 resource
Available online
Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.
1995
1 resource
Available online
Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
1996
1 resource
Available online
Cancer patient access to unapproved treatments : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
1996
2 resources
Available online
The need for FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 27, 1996.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
1996
1 resource
Available online
Medical device regulation : too early to assess European system's value as model for FDA : report to the Chairman, Committee on Labor and Human Resources, U.S. Senate / United States General Accounting Office.
Book/text
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1996]
1996
1 resource
Available online
FDA reform legislation : hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
1996
1 resource
Available online
FDA integrity issues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on VISX, Inc. document disclosure, July 31, 1996.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
1996
2 resources
Available online
Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996 [i.e. 1997]
1997
1 resource
Available online
FDA import automation : serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1995]
1995
0 resources
FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
1997
1 resource
Available online
FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Microform
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1995]
1995
1 resource
Available online
Medical devices : FDA review time : report to the chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives.
Microform
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1995]
1995
1 resource
Available online
Medical devices : technological innovation and patient/provider perspectives : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, May 30, 1997.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
1997
2 resources
Available online
Reauthorization of the Prescription Drug User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
1997
2 resources
Available online
FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives.
Microform
Washington, D.C. (441 G St., NW, Rm. Lm, Washington 20548) : U.S. General Accounting Office, [1996]
1996
1 resource
Available online
Blood safety : enhancing safeguards would strengthen the nation's blood supply : statement of Bernice Steinhardt, Director, Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources, Committee on Government Reform and Oversight, House of Representatives / United States General Accounting Office.
Microform
Washington, D.C. : The Office, [1997]
1997
1 resource
Available online
Medical devices : FDA review times, 1989 through 1996 / United States General Accounting Office, Health, Education and Human Services Division.
Microform
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1997]
1997
0 resources
Blood supply : FDA oversight and remaining issues of safety : report to the ranking minority member, Committee on Commerce, House of Representatives.
Microform
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1997]
1997
1 resource
Available online
Blood supply : transfusion-associated risks : report to the ranking minority member, Committee on Commerce, House of Representatives.
Microform
Washington, D.C. (441 G St., NW, Rm. LM, Washington 20548) : U.S. General Accounting Office, [1997]
1997
1 resource
Available online
Food and Drug Administration : regulation of tobacco products : report to congressional requesters / United States General Accounting Office.
Microform
Washington, D.C. : The Office, [1997]
1997
1 resource
Available online
Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.
Book/text
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1998.
1998
3 resources
Available online
Food safety : federal oversight of shellfish safety needs improvement : report to the Committee on Agriculture, Nutrition, and Forestry, U.S. Senate / United States General Accounting Office.
Web resource
[Washington, D.C.] : The Office, [2001]
2001
1 resource
Available online
Changes in FDA structure / United States General Accounting Office, Health, Education and Human Services Division.
Microform
Washington, D.C. (P.O. Box 37050, Washington 20013) : The Office, [1995]
1995
0 resources
FDA resources / United States General Accounting Office, Program Evaluation and Methodology Division.
Microform
Washington, D.C. (P.O. Box 37050, Washington 20013) : The Office, [1996]
1996
0 resources